Constellation loses on nuclear write-downs
Not including the nuclear joint venture and other costs, Constellation said it would have earned 48 cents per share for the third quarter of 2010, 16 cents less than the average estimate of nine analysts surveyed by Bloomberg. In the third quarter of 2009, Constellation had adjusted earnings of $1.23 per share.
“During the third quarter, we continued to see solid results from our core businesses and we advanced on several key acquisitions and objectives,” Mayo A. Shattuck III, Constellation CEO and president, said in a recent statement. “Our NewEnergy platform performed well, as our customer-facing power and gas businesses exceeded many of our plan metrics in an environment of low commodity prices and heightened competition.
Profit was reduced 14 cents by quarterly adjustments to the value of contracts used to lock in the prices and cost of electricity and gas Constellation sells, Chief Financial Officer Jonathan W. Thayer said on an investor call.
“Power prices are down, hedged power prices are down, and they’d sold 50 percent of their nuclear generation,” Angie Storozynski, a New York-based analyst for Macquarie Capital USA Inc., said in a telephone interview. She rates the stock “outperform” and doesn’t own any shares.
Slumping power prices slashed the value of ConstellationÂ’s stake in three nuclear plants co-owned with Paris-based Electricite de France by $1.35 billion, or $6.70 a share, the company said. Forecasts of low future power prices prompted the company to withdraw from talks on a government loan guarantee for a new reactor in Maryland. EDF agreed last week to pay about $249 million for ConstellationÂ’s stake in the companiesÂ’ nuclear venture.
A write-down of that venture, UniStar Nuclear Energy, reduced results for the quarter by $86.3 million, or 43 cents, and the company also wrote down stakes in three coal-burning power plants in California by $32.5 million. It had a 12 cent per-share gain on the sale of its stake in a geothermal plant in California to partner Ormat Technologies Inc. for $72.5 million.
“We were pleased to announce a comprehensive agreement with EDF Group on terms that are very favorable to our company,” said Shattuck. “This agreement resolves the contractual put option and transfers full ownership of the UniStar nuclear development business to EDF.
Constellation agreed to transfer its half of UniStar as well as its interest in potential nuclear power development at sites at Calvert Cliffs, Nine Mile Point and R.E. Ginna, in New York to EDF for $249 million in cash and stock. The deal also ended an impasse over a “put option” where Constellation could have forced EDF to buy 12 of its coal-fired power plants for up to $2 billion.
The company also affirmed earnings guidance of $3.05 to $3.45 a share for the rest of 2010. The average estimate is $3.23 among 11 analysts.
Related News

Jolting the brain's circuits with electricity is moving from radical to almost mainstream therapy
SAN FRANCISCO - In June 2015, biology professor Colleen Hanlon went to a conference on drug dependence. As she met other researchers and wandered around a glitzy Phoenix resort’s conference rooms to learn about the latest work on therapies for drug and alcohol use disorders, she realized that out of the 730 posters, there were only two on brain stimulation as a potential treatment for addiction — both from her own lab at Wake Forest School of Medicine.
Just four years later, she would lead 76 researchers on four continents in writing a consensus article about brain stimulation as an innovative…